Inhibition of hyaluronan secretion by novel coumarin compounds and chitin synthesis inhibitors
Open Access
- 8 May 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Glycobiology
- Vol. 31 (8) , 959-974
Abstract
Elevated plasma levels of hyaluronic acid (HA) is a disease marker in liver pathology and other inflammatory disorders. Inhibition of HA synthesis with coumarin 4-methylumbelliferone (4MU) has a beneficial effect in animal models of fibrosis, inflammation, cancer and metabolic syndrome. 4MU is an active compound of approved choleretic drug hymecromone with low bioavailability and a broad spectrum of action. New, more specific and efficient inhibitors of hyaluronan synthases (HAS) are required. We have tested several newly synthesized coumarin compounds and commercial chitin synthesis inhibitors to inhibit HA production in cell culture assay. Coumarin derivative compound VII (10′-methyl-6′-phenyl-3′H-spiro[piperidine-4,2′-pyrano[3,2-g]chromene]-4′,8′-dione) demonstrated inhibition of HA secretion by NIH3T3 cells with the half-maximal inhibitory concentration (IC50) = 1.69 ± 0.75 μΜ superior to 4MU (IC50 = 8.68 ± 1.6 μΜ). Inhibitors of chitin synthesis, etoxazole, buprofezin, triflumuron, reduced HA deposition with IC50 of 4.21 ± 3.82 μΜ, 1.24 ± 0.87 μΜ and 1.48 ± 1.44 μΜ, respectively. Etoxazole reduced HA production and prevented collagen fibre formation in the CCl4 liver fibrosis model in mice similar to 4MU. Bioinformatics analysis revealed homology between chitin synthases and HAS enzymes, particularly in the pore-forming domain, containing the proposed site for etoxazole binding.Keywords
Funding Information
- Russian Foundation for Basic Research (19-29-04123)
- Koltzov Institute of Developmental Biology of the Russian Academy of Sciences (0088-2021-0017)
This publication has 69 references indexed in Scilit:
- Hyaluronan: A critical regulator of endothelial-to-mesenchymal transition during cardiac valve formationTrends in Cardiovascular Medicine, 2013
- Population bulk segregant mapping uncovers resistance mutations and the mode of action of a chitin synthesis inhibitor in arthropodsProceedings of the National Academy of Sciences, 2012
- Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal ResearchPLOS Biology, 2010
- 4-Methylumbelliferone inhibits hyaluronan synthesis by depletion of cellular UDP-glucuronic acid and downregulation of hyaluronan synthase 2 and 3Experimental Cell Research, 2009
- Study of hyaluronan synthase inhibitor, 4-methylumbelliferone derivatives on human pancreatic cancer cell (KP1-NL)Biochemical and Biophysical Research Communications, 2006
- MUSCLE: multiple sequence alignment with high accuracy and high throughputNucleic Acids Research, 2004
- VMD: Visual molecular dynamicsJournal of Molecular Graphics, 1996
- Hyaluronic-Acid-Deficient Extracellular Matrix Induced by Addition of 4-Methylumbelliferone to the Medium of Cultured Human Skin FibroblastsBiochemical and Biophysical Research Communications, 1995
- The Streptococcus pyogenes Hyaluronan Synthase: Sequence Comparison and Conservation among Various Group A StrainsBiochemical and Biophysical Research Communications, 1994
- Accumulation and decay of DG42 gene products follow a gradient pattern during Xenopus embryogenesisDevelopmental Biology, 1988